/
NDRA
$5.00+$0.01 (+0.20%)prev close
Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Market cap
$9.2M
2M shares
52-week range
$2.96 – $11.96
23% from low
Sector
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Exchange
NASDAQ
CS
Borrow rate
15.44%
Hard to borrow
Price (6 mo)
Loading chart…
Change$-75245.00
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $6.2K | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cost of revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross profit | $6.2K | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross margin | 100.0% | — | — | — | — | — | — | — |
| R&D | $4.7M | $6.6M | $5.9M | $5.5M | $6.6M | $5.0M | $3.2M | $1.8M |
| Operating income | −$9.0M | −$10.8M | −$11.5M | −$11.5M | −$13.2M | −$10.5M | −$10.8M | −$5.8M |
| EBITDA | −$9.0M | −$10.8M | −$11.3M | −$11.0M | −$12.9M | −$9.8M | −$11.3M | −$6.9M |
| Net income | −$9.8M | −$13.3M | −$11.7M | −$11.2M | −$13.2M | −$10.1M | −$11.5M | −$7.0M |
| Net margin | -158669.6% | — | — | — | — | — | — | — |
| EPS (diluted) | -43.49 | -41.48 | -12.47 | -5.47 | -6.84 | -5.89 | -10.25 | -8.93 |
Annual figures · source: Financial Modeling Prep
Analyst estimates (consensus)
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $100000 | $-3.54 | $-3.54–$-3.54 | 1 |
| 2027 | $200000 | $-3.04 | $-3.04–$-3.04 | 1 |
Forward consensus · source: Financial Modeling Prep
Peer comparison
ENDRA Life Sciences Inc. Common Stock
ENDRA Life Sciences Inc is engaged in the development of thermo-acoustic enhanced ultrasound (TAEUS) technology to improve the capabilities of clinical diagnostic ultrasound. The company's technology is used to measure tissue composition, including the assessment of fat in the liver, and is being developed for additional clinical applications such as tissue temperature monitoring.
www.endrainc.com- Employees
- 11
- IPO / List date
- Jun 28, 2017
- HQ
- ANN ARBOR, MI
Held by traders on TradeandTell
No one on the platform currently holds NDRA.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in NDRA as of their last filing.
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2024-11-07 | 1-for-35reverse |
| 2024-08-20 | 1-for-50reverse |
| 2022-12-09 | 1-for-20reverse |
Recent trades on TradeandTell
No one on the platform has traded NDRA yet.
